Alinia (Avera McKennan Hospital)


Welcome to the PulseAid listing for the Alinia drug offered from Avera McKennan Hospital. This Antiprotozoal [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Avera McKennan Hospital
NON-PROPRIETARY NAME: nitazoxanide
SUBSTANCE NAME: NITAZOXANIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Antiprotozoal [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2015-05-26
END MARKETING DATE: 0000-00-00


Alinia HUMAN PRESCRIPTION DRUG Details:

Item DescriptionAlinia from Avera McKennan Hospital
LABELER NAME: Avera McKennan Hospital
DEA SCHEDULE:
ACTIVE STRENGTH: 500(mg/1)
START MARKETING DATE: 2015-05-26
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69189-0243_1a109930-2b98-4b0e-a850-5c453065ec3a
PRODUCT NDC: 69189-0243
APPLICATION NUMBER: NDA021497

Other NITAZOXANIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalAlinia
Lupin PharmaAlinia
Romark Laboratories, L.C.Alinia